Ikon World News
Linkedin

Ikon World News

Alakanuk : AK : USA | Mar 11, 2011 at 1:26 AM PST
By
XX XX
Views: Pending
 
HGSI Exclusive with StockMarketFunding.com CEO Mario Marciano on Benlysta for Lupus Drug
Latest News: Human Genome Sciences HGSI's leadership on Wednesday announced the approval of drugs Benlysta. Take moderate estimate of fair value us as we plan our move to 100 percent chance of approval and to $ 35,000 per year to increase the cost of our expectations. Our best assumptions.We, mainly reflects the firm and its partner, GlaxoSmithKline GSK, quarter.Benlysta second "fully approved drugs will launch a drug for lupus in 50 more years before all signs of approval. FDA active, positive autoantibodies adult patients with systemic lupus erythematosus SLE receiving standard therapy for Benlysta approved label, as requested by the human genome.
1 of 2
Next
US health officials announced approval of the first new drug in 56 years to treat lupus
US health officials announced approval of the first new drug in 56 years to treat lupus
amnan is based in Islamabad, Federal Capital Area, Pakistan, and is a Stringer on Allvoices.
Report Credibility
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
 
Advertisement
 

News Stories

 
  • FDA Approves First New Lupus Drug In More Than 50 Years

      National Public Radio
    The Food and Drug Administration just approved a lupus drug called Benlysta , whose roots go back to 1996, when the genome gold rush was in full swing. Most of the hype back then about how deciphering the human genetic code would quickly usher in a...
  • New Lupus Drug Benlysta Approved

    The FDA has approved Benlysta, the first new lupus drug since 1955. Benlysta is approved for the treatment of patients with active, autoantibody-positive lupus who are getting standard therapy...As many as 1.5 million Americans have systemic lupus...
  • First new lupus drug in 50 years

      United Press International
    The drug Benlysta, or belimumab, has been approved by the U.S. Food and Drug Administration to treat the most common type of lupus...Lerner, president of Scripps Research, said Benlysta, developed by GlaxoSmithKline and Human Genome Sciences, is the...
  • The New Lupus Drug: What The Wags Are Saying

      Pharmalot
    Every so often, a new approval generates significant attention. And the FDA endorsement of Benlysta, the first new treatment for lupus in 56 years, is one of those moments. The injectable med, which will be marketed by Human Genome Sciences and...
  • U.S. Approves First New Lupus Drug in 50 Years

      Fox News
    Reuters The first new treatment for lupus in a half-century won U.S. approval on Wednesday, a milestone for patients with the disabling disease and a potential blockbuster for its tiny biotech maker. Health officials cleared Benlysta, discovered by...
  • Glaxo Expects More Products From Gene Research

      Asian Wall Street Journal
    After waiting 18 years for its partnership with Human Genome Sciences Inc. to bear fruit, drug giant GlaxoSmithKline PLC hopes the Food and Drug Administration's approval of a new lupus treatment discovered by Human Genome Sciences is just the first...

Blogs

 >

Images

 >
 

More From Allvoices

Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Most Commented Reports



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.